Disclosures for "Clinical and Molecular Landscape of Amyotrophic Lateral Sclerosis Patients with OPTN Variants from Turkey and Possible Therapeutic Response to Inhibation of RIPK1"
-
Dr. Durmus has nothing to disclose.
-
Dr. Erzurumluoglu Gokalp has nothing to disclose.
-
Prof. Gezen-Ak has nothing to disclose.
-
Prof. Dursun has nothing to disclose.
-
Dr. Alaylioglu has nothing to disclose.
-
Author has nothing to disclose
-
Prof. Uyguner has nothing to disclose.
-
ESEN KIYAN has nothing to disclose.
-
Dr. Parman has nothing to disclose.